Dr. Walter Stadler shares insights on the current treatment landscape for prostate and bladder cancers and emphasizes the importance of improving access to care for all patients.

Dr. Enrique Velazquez Villarreal, Assistant Professor in Department of Integrative Translational Sciences at City of Hope, discusses how his innovative AI tool, AI-HOPE, is revolutionizing cancer care by combining clinical data, genomics, and social determinants of health to enhance personalized treatments and patient outcomes.

Dr. Ghassan Abou-Alfa, a renowned medical oncologist at Memorial Sloan Kettering Cancer Center, discusses the global impact of cholangiocarcinoma and the pivotal role of the CCA Summit in driving research, collaboration, and improved patient care.

Join Maimah Karmo, founder and CEO of the Tigerlily Foundation and 20-year triple-negative breast cancer survivor, as she shares her inspiring journey of resilience and highlights Tigerlily’s transformative programs to empower women in the fight against breast cancer.

In Part 2 of our interview with Maimah Karmo we dive deeper into her advocacy work addressing health disparities in breast cancer care. Discover how Tigerlily is driving change through initiatives that empower underrepresented communities and advance equity in cancer outcomes.

Listen to Dr. Shanthi Sivendran, Senior Vice President of Cancer Care Support at the American Cancer Society and practicing medical oncologist, as she shines a spotlight on the ACS’s powerful, life-changing programs that support to patients and their families every step of the way.

Dr. Omid Hamid, Chief of Research and Immuno-Oncology at The Angeles Clinic and Research Institute, discusses advancements in immuno-oncology and shares his vision for the future of cancer care innovation.

Join us for the next part of our interview with Dr. Shanthi Sivendran, where she highlights the American Cancer Society’s transformative programs that provide vital support to patients and their families.

Hear from Dr. Greg Kalemkerian, a leading medical oncologist and professor at the University of Michigan, as he provides expert insights into the evolving landscape of lung cancer treatment.